Cardiovascular drugs in human mechanical nociception: digoxin, amlodipine,
propranolol, pindolol and atenolol.
Author(s): Del Giaccio A, Eblen-Zajjur A.
Affiliation(s): Servicio de Medicina Interna, Hospital Universitario Dr. Angel Larralde,
Instituto Venezolano de los Seguros Sociales, Venezuela.
Publication date & source: 2010, Invest Clin. , 51(1):77-86
Calcium channel blockers, beta adrenergic receptor blockers and Na/K ATPase
inhibitors are widely used drugs, mainly for cardiovascular diseases. Their
pharmacological targets are not restricted to the cardivascular tissue,
nociceptive system structures also express similar targets, which strongly
suggests a direct effect on pain sensation. To evaluate the pain intensity
changes in outpatient groups, who receive these drugs as a therapy, a
cross-sectional sampled, randomized patient groups receiving the calcium channel
blocker amlodipine for blood hypertension (n=45), beta adrenergic receptor
blockers (propranolol, atenolol or pindolol; n=40) for blood hypertension, or
digoxin (n=40) for heart failure, were compared to an aparently healthy
volunteers control group (n=60). A calibrated noxious pressure of 890 g/mm2 was
applied for 5 seconds on the patient's sternum. Subjective pain intensity was
reported by the visual analog scale (VAS, 0 to 10). Pain modulation system was
evaluated by the application of a second stimulus with a 5 minutes delay. The
analgesic effect of the beta blockers group (propanolol, atenolol, pindolol) was
dosage-dependant (-36.8%; P = 0.0000003), without differences among them. The
calcium channel blocker amlodipine showed lower pain scores (-50.6%; P =
0.0000003) than beta-receptor blockers (P = 0.0000003). Digoxin presented the
highest pain scores (+56.5%; P = 0.0000003). All pain scores for the second
stimulus were lower than the first stimulus and were differentially affected by
beta-blockers (atenolol, pindolol and propanolol) and calcium channel blocker
(amlodipine), but not by digoxin. These results suggest the influence of widely
clinically used cardiovascular drugs on nociception.
|